カテゴリー： FactMR, 世界, 医療/バイオ

ペプチド治療薬（メタボリックシンドローム用）の世界市場2023年～2033年：予測・動向・分析・競争状況

◆英語タイトル：Peptide-based Metabolic Disorders Therapeutics Market By Drug (Liraglutide, Exenatide), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), & Region - Global Market Insights 2023 to 2033

FactMRが発行した調査報告書（FACT23AP103）◆商品コード：FACT23AP103
◆発行会社（リサーチ会社）：FactMR
◆発行日：2023年1月17日
◆ページ数：約170
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧、印刷不可）USD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
Global Site License（同一拠点内共有可）USD8,500 ⇒換算￥1,292,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ファクトエムアール社の本調査資料は、2023年から2033年までの世界のペプチド治療薬（メタボリックシンドローム用）市場の現状・動向について調査した最新レポートです。エグゼクティブサマリー、市場概要、治療薬別（リラグルチド、エキセナチド、その他）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別（北米、中南米、ヨーロッパ、日本、東アジア、南アジア、東南アジア、オセアニア、中東/アフリカ）分析、競争状況・会社概要、調査方法、二次情報源・一次情報源、仮定などの構成でまとめております。なお、当レポートには、AstraZeneca plc、Bachem Holding AG、CordenPharma Internationalなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場概要
・世界のペプチド治療薬（メタボリックシンドローム用）市場規模：治療薬別
　- リラグルチドの市場規模
　- エキセナチドの市場規模
　- その他治療薬の市場規模
・世界のペプチド治療薬（メタボリックシンドローム用）市場規模：流通チャネル別
　- 病院薬局の市場規模
　- 小売薬局の市場規模
　- オンライン薬局の市場規模
・世界のペプチド治療薬（メタボリックシンドローム用）市場規模：地域別
　- 北米のペプチド治療薬（メタボリックシンドローム用）市場規模
　- 中南米のペプチド治療薬（メタボリックシンドローム用）市場規模
　- ヨーロッパのペプチド治療薬（メタボリックシンドローム用）市場規模
　- 日本のペプチド治療薬（メタボリックシンドローム用）市場規模
　- 東アジアのペプチド治療薬（メタボリックシンドローム用）市場規模
　- 南アジアのペプチド治療薬（メタボリックシンドローム用）市場規模
　- 東南アジアのペプチド治療薬（メタボリックシンドローム用）市場規模
　- オセアニアのペプチド治療薬（メタボリックシンドローム用）市場規模
　- 中東/アフリカのペプチド治療薬（メタボリックシンドローム用）市場規模
・競争状況・会社概要
・調査方法
・二次情報源・一次情報源
・仮定

本資料には、各企業の製品ポートフォリオや主要戦略、包括的なSWOT分析などの要素を含む企業情報が含まれています。企業のプレゼンスは、全著名プレーヤーについてマッピングされ、マトリックスを通して提示されます。また、読者に実用的な洞察を提供し、熟考して市場の状況を示し、ペプチド治療薬（メタボリックシンドローム用）における競争レベルを推測するのに役立ちます。

Peptide-based Metabolic Disorders Therapeutics Market – Scope of Report

A recent study by Fact.MR on the peptide-based metabolic disorders therapeutics market offers a 10-year forecast for 2023 to 2033. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering peptide-based metabolic disorders therapeutics.

The study also provides the dynamics responsible for influencing the future status of the peptide-based metabolic disorders therapeutics market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report.

A list of prominent companies operating in the peptide-based metabolic disorders therapeutics market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of peptide-based metabolic disorders therapeutics across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of peptide-based metabolic disorders therapeutics during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for peptide-based metabolic disorders therapeutics are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report.

Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global peptide-based metabolic disorders therapeutics market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the peptide-based metabolic disorders therapeutics market during the forecast period.

Country-specific valuation on demand for peptide-based metabolic disorders therapeutics has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading manufacturers of peptide-based metabolic disorders therapeutics, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering peptide-based metabolic disorders therapeutics has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the peptide-based metabolic disorders therapeutics domain.

❖ レポートの目次 ❖

1. Global Market – Executive Summary

2. Global Market Overview

    2.1. Introduction

       2.1.1. Global Market Taxonomy

       2.1.2. Global Market Definition

    2.2. Global Market Size (US$ Mn) and Forecast, 2018-2033

       2.2.1. Global Market Y-o-Y Growth

    2.3. Global Market Dynamics

    2.4. Regulations

    2.5. Supply Chain

    2.6. Cost Structure

    2.7. Average Pricing Analysis

    2.8. Epidemiology

    2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Market Analysis and Forecast By Drug

    3.1. Global Market Size and Forecast By Drug, 2018-2033

       3.1.1. Liraglutide Market Size and Forecast, 2018-2033

            3.1.1.1. Revenue (US$ Mn) Comparison, By Region

            3.1.1.2. Market Share Comparison, By Region

            3.1.1.3. Y-o-Y growth Comparison, By Region

       3.1.2. Exenatide Market Size and Forecast, 2018-2033

            3.1.2.1. Revenue (US$ Mn) Comparison, By Region

            3.1.2.2. Market Share Comparison, By Region

            3.1.2.3. Y-o-Y growth Comparison, By Region

       3.1.3. Others Market Size and Forecast, 2018-2033

            3.1.3.1. Revenue (US$ Mn) Comparison, By Region

            3.1.3.2. Market Share Comparison, By Region

            3.1.3.3. Y-o-Y growth Comparison, By Region

4. Global Market Analysis and Forecast By Distribution Channel

    4.1. Global Market Size and Forecast By Distribution Channel, 2018-2033

       4.1.1. Hospital Pharmacies Market Size and Forecast, 2018-2033

            4.1.1.1. Revenue (US$ Mn) Comparison, By Region

            4.1.1.2. Market Share Comparison, By Region

            4.1.1.3. Y-o-Y growth Comparison, By Region

       4.1.2. Retail Pharmacies Market Size and Forecast, 2018-2033

            4.1.2.1. Revenue (US$ Mn) Comparison, By Region

            4.1.2.2. Market Share Comparison, By Region

            4.1.2.3. Y-o-Y growth Comparison, By Region

       4.1.3. Online Pharmacies Market Size and Forecast, 2018-2033

            4.1.3.1. Revenue (US$ Mn) Comparison, By Region

            4.1.3.2. Market Share Comparison, By Region

            4.1.3.3. Y-o-Y growth Comparison, By Region

5. Global Market Analysis and Forecast By Region

    5.1. Global Market Size and Forecast, 2018-2033

       5.1.1. North America Market Size and Forecast, 2018-2033

            5.1.1.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

       5.1.2. Latin America Market Size and Forecast, 2018-2033

            5.1.2.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

       5.1.3. Europe Market Size and Forecast, 2018-2033

            5.1.3.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

       5.1.4. Japan Market Size and Forecast, 2018-2033

            5.1.4.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel

       5.1.5. APEJ Market Size and Forecast, 2018-2033

            5.1.5.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel

       5.1.6. MEA Market Size and Forecast, 2018-2033

            5.1.6.1. Revenue (US$ Mn) Comparison, By Drug

            5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel

6. North America Market Analysis and Forecast, By Country, 2018-2033

    6.1. US Market Size and Forecast, 2018-2033

       6.1.1. Revenue (US$ Mn) Comparison, By Drug

       6.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    6.2. Canada Market Size and Forecast, 2018-2033

       6.2.1. Revenue (US$ Mn) Comparison, By Drug

       6.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

7. Latin America Market Analysis and Forecast, By Country, 2018-2033

    7.1. Brazil Market Size and Forecast, 2018-2033

       7.1.1. Revenue (US$ Mn) Comparison, By Drug

       7.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    7.2. Mexico Market Size and Forecast, 2018-2033

       7.2.1. Revenue (US$ Mn) Comparison, By Drug

       7.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    7.3. Argentina Market Size and Forecast, 2018-2033

       7.3.1. Revenue (US$ Mn) Comparison, By Drug

       7.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

8. Europe Market Analysis and Forecast, By Country, 2018-2033

    8.1. Germany Market Size and Forecast, 2018-2033

       8.1.1. Revenue (US$ Mn) Comparison, By Drug

       8.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.2. UK Market Size and Forecast, 2018-2033

       8.2.1. Revenue (US$ Mn) Comparison, By Drug

       8.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.3. France Market Size and Forecast, 2018-2033

       8.3.1. Revenue (US$ Mn) Comparison, By Drug

       8.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.4. Spain Market Size and Forecast, 2018-2033

       8.4.1. Revenue (US$ Mn) Comparison, By Drug

       8.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.5. Italy Market Size and Forecast, 2018-2033

       8.5.1. Revenue (US$ Mn) Comparison, By Drug

       8.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    8.6. Nordic Market Size and Forecast, 2018-2033

       8.6.1. Revenue (US$ Mn) Comparison, By Drug

       8.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel

9. Japan Market Analysis and Forecast, By Country, 2018-2033

    9.1. Japan Market Size and Forecast, 2018-2033

       9.1.1. Revenue (US$ Mn) Comparison, By Drug

       9.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

10. APEJ Market Analysis and Forecast, By Country, 2018-2033

    10.1. China Market Size and Forecast, 2018-2033

       10.1.1. Revenue (US$ Mn) Comparison, By Drug

       10.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.2. India Market Size and Forecast, 2018-2033

       10.2.1. Revenue (US$ Mn) Comparison, By Drug

       10.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.3. Malaysia Market Size and Forecast, 2018-2033

       10.3.1. Revenue (US$ Mn) Comparison, By Drug

       10.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.4. Thailand Market Size and Forecast, 2018-2033

       10.4.1. Revenue (US$ Mn) Comparison, By Drug

       10.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.5. Singapore Market Size and Forecast, 2018-2033

       10.5.1. Revenue (US$ Mn) Comparison, By Drug

       10.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    10.6. Australia Market Size and Forecast, 2018-2033

       10.6.1. Revenue (US$ Mn) Comparison, By Drug

       10.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel

11. MEA Market Analysis and Forecast, By Country, 2018-2033

    11.1. GCC Countries Market Size and Forecast, 2018-2033

       11.1.1. Revenue (US$ Mn) Comparison, By Drug

       11.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    11.2. South Africa Market Size and Forecast, 2018-2033

       11.2.1. Revenue (US$ Mn) Comparison, By Drug

       11.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    11.3. Nigeria Market Size and Forecast, 2018-2033

       11.3.1. Revenue (US$ Mn) Comparison, By Drug

       11.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel

    11.4. Israel Market Size and Forecast, 2018-2033

       11.4.1. Revenue (US$ Mn) Comparison, By Drug

       11.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel

12. Global Market Competition Landscape and Company Profile

    12.1. Company Share Analysis By Region

        12.1.1. AstraZeneca plc

            12.1.1.1. Company Overview

            12.1.1.2. Market Drug list

            12.1.1.3. Market Drug Sales Data and Key Financials

            12.1.1.4. Key Developments

            12.1.1.5. SWOT Analysis

        12.1.2. Bachem Holding AG

            12.1.2.1. Company Overview

            12.1.2.2. Market Drug list

            12.1.2.3. Market Drug Sales Data and Key Financials

            12.1.2.4. Key Developments

            12.1.2.5. SWOT Analysis

        12.1.3. CordenPharma International

            12.1.3.1. Company Overview

            12.1.3.2. Market Drug list

            12.1.3.3. Market Drug Sales Data and Key Financials

            12.1.3.4. Key Developments

            12.1.3.5. SWOT Analysis

        12.1.4. Eli Lilly and Company

            12.1.4.1. Company Overview

            12.1.4.2. Market Drug list

            12.1.4.3. Market Drug Sales Data and Key Financials

            12.1.4.4. Key Developments

            12.1.4.5. SWOT Analysis

        12.1.5. Ipsen S.A

            12.1.5.1. Company Overview

            12.1.5.2. Market Drug list

            12.1.5.3. Market Drug Sales Data and Key Financials

            12.1.5.4. Key Developments

            12.1.5.5. SWOT Analysis

        12.1.6.. Merck & Co., Inc

            12.1.6.1. Company Overview

            12.1.6.2. Market Drug list

            12.1.6.3. Market Drug Sales Data and Key Financials

            12.1.6.4. Key Developments

            12.1.6.5. SWOT Analysis

        12.1.7. Novo Nordisk A/S

            12.1.7.1. Company Overview

            12.1.7.2. Market Drug list

            12.1.7.3. Market Drug Sales Data and Key Financials

            12.1.7.4. Key Developments

            12.1.7.5. SWOT Analysis

        12.1.8. PolyPeptide Group

            12.1.8.1. Company Overview

            12.1.8.2. Market Drug list

            12.1.8.3. Market Drug Sales Data and Key Financials

            12.1.8.4. Key Developments

            12.1.8.5. SWOT Analysis

        12.1.9. Teva Pharmaceutical Industries Ltd

            12.1.9.1. Company Overview

            12.1.9.2. Market Drug list

            12.1.9.3. Market Drug Sales Data and Key Financials

            12.1.9.4. Key Developments

            12.1.9.5. SWOT Analysis

13. Research Methodology

14. Secondary and Primary Sources

15. Assumptions and Acronyms

16. Disclaimer

Table  1: Global Market Value (US$ Mn), 2018-2022

Table  2: Global Market Value (US$ Mn), 2023-2033

Table  3: Global Market Value (US$ Mn) and Y-o-Y, 2015-2033

Table  4: Global Liraglutide Segment Value (US$ Mn), By Region 2018-2022

Table  5: Global Liraglutide Segment Value (US$ Mn), By Region 2023-2033

Table  6: Global Liraglutide Segment Market Share, By Region 2018-2022

Table  7: Global Liraglutide Segment Market Share, By Region 2023-2033

Table  8: Global Liraglutide Segment Y-o-Y, By Region 2015-2033

Table  9: Global Exenatide Segment Value (US$ Mn), By Region 2018-2022

Table  10: Global Exenatide Segment Value (US$ Mn), By Region 2023-2033

Table  11: Global Exenatide Segment Market Share, By Region 2018-2022

Table  12: Global Exenatide Segment Market Share, By Region 2023-2033

Table  13: Global Exenatide Segment Y-o-Y, By Region 2015-2033

Table  14: Global Others Segment Value (US$ Mn), By Region 2018-2022

Table  15: Global Others Segment Value (US$ Mn), By Region 2023-2033

Table  16: Global Others Segment Market Share, By Region 2018-2022

Table  17: Global Others Segment Market Share, By Region 2023-2033

Table  18: Global Others Segment Y-o-Y, By Region 2015-2033

Table  19: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2022

Table  20: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2023-2033

Table  21: Global Hospital Pharmacies Segment Market Share, By Region 2018-2022

Table  22: Global Hospital Pharmacies Segment Market Share, By Region 2023-2033

Table  23: Global Hospital Pharmacies Segment Y-o-Y, By Region 2015-2033

Table  24: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2022

Table  25: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2023-2033

Table  26: Global Retail Pharmacies Segment Market Share, By Region 2018-2022

Table  27: Global Retail Pharmacies Segment Market Share, By Region 2023-2033

Table  28: Global Retail Pharmacies Segment Y-o-Y, By Region 2015-2033

Table  29: Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2022

Table  30: Global Online Pharmacies Segment Value (US$ Mn), By Region 2023-2033

Table  31: Global Online Pharmacies Segment Market Share, By Region 2018-2022

Table  32: Global Online Pharmacies Segment Market Share, By Region 2023-2033

Table  33: Global Online Pharmacies Segment Y-o-Y, By Region 2015-2033

Table  34: North America Market Value (US$ Mn), By Drug 2018-2022

Table  35: North America Market Value (US$ Mn), By Drug 2023-2033

Table  36: North America Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  37: North America Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  38: Latin America Market Value (US$ Mn), By Drug 2018-2022

Table  39: Latin America Market Value (US$ Mn), By Drug 2023-2033

Table  40: Latin America Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  41: Latin America Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  42: Europe Market Value (US$ Mn), By Drug 2018-2022

Table  43: Europe Market Value (US$ Mn), By Drug 2023-2033

Table  44: Europe Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  45: Europe Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  46: Japan Market Value (US$ Mn), By Drug 2018-2022

Table  47: Japan Market Value (US$ Mn), By Drug 2023-2033

Table  48: Japan Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  49: Japan Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  50: APEJ Market Value (US$ Mn), By Drug 2018-2022

Table  51: APEJ Market Value (US$ Mn), By Drug 2023-2033

Table  52: APEJ Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  53: APEJ Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  54: MEA Market Value (US$ Mn), By Drug 2018-2022

Table  55: MEA Market Value (US$ Mn), By Drug 2023-2033

Table  56: MEA Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  57: MEA Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  58: US Market Value (US$ Mn), By Drug 2018-2022

Table  59: US Market Value (US$ Mn), By Drug 2023-2033

Table  60: US Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  61: US Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  62: Canada Market Value (US$ Mn), By Drug 2018-2022

Table  63: Canada Market Value (US$ Mn), By Drug 2023-2033

Table  64: Canada Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  65: Canada Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  66: Brazil Market Value (US$ Mn), By Drug 2018-2022

Table  67: Brazil Market Value (US$ Mn), By Drug 2023-2033

Table  68: Brazil Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  69: Brazil Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  70: Mexico Market Value (US$ Mn), By Drug 2018-2022

Table  71: Mexico Market Value (US$ Mn), By Drug 2023-2033

Table  72: Mexico Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  73: Mexico Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  74: Argentina Market Value (US$ Mn), By Drug 2018-2022

Table  75: Argentina Market Value (US$ Mn), By Drug 2023-2033

Table  76: Argentina Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  77: Argentina Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  78: Germany Market Value (US$ Mn), By Drug 2018-2022

Table  79: Germany Market Value (US$ Mn), By Drug 2023-2033

Table  80: Germany Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  81: Germany Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  82: UK Market Value (US$ Mn), By Drug 2018-2022

Table  83: UK Market Value (US$ Mn), By Drug 2023-2033

Table  84: UK Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  85: UK Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  86: France Market Value (US$ Mn), By Drug 2018-2022

Table  87: France Market Value (US$ Mn), By Drug 2023-2033

Table  88: France Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  89: France Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  90: Spain Market Value (US$ Mn), By Drug 2018-2022

Table  91: Spain Market Value (US$ Mn), By Drug 2023-2033

Table  92: Spain Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  93: Spain Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  94: Italy Market Value (US$ Mn), By Drug 2018-2022

Table  95: Italy Market Value (US$ Mn), By Drug 2023-2033

Table  96: Italy Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  97: Italy Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  98: Nordic Market Value (US$ Mn), By Drug 2018-2022

Table  99: Nordic Market Value (US$ Mn), By Drug 2023-2033

Table  100: Nordic Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  101: Nordic Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  102: Japan  Market Value (US$ Mn), By Drug 2018-2022

Table  103: Japan  Market Value (US$ Mn), By Drug 2023-2033

Table  104: Japan  Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  105: Japan  Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  106: China Market Value (US$ Mn), By Drug 2018-2022

Table  107: China Market Value (US$ Mn), By Drug 2023-2033

Table  108: China Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  109: China Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  110: India Market Value (US$ Mn), By Drug 2018-2022

Table  111: India Market Value (US$ Mn), By Drug 2023-2033

Table  112: India Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  113: India Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  114: Malaysia Market Value (US$ Mn), By Drug 2018-2022

Table  115: Malaysia Market Value (US$ Mn), By Drug 2023-2033

Table  116: Malaysia Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  117: Malaysia Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  118: Thailand Market Value (US$ Mn), By Drug 2018-2022

Table  119: Thailand Market Value (US$ Mn), By Drug 2023-2033

Table  120: Thailand Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  121: Thailand Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  122: Singapore Market Value (US$ Mn), By Drug 2018-2022

Table  123: Singapore Market Value (US$ Mn), By Drug 2023-2033

Table  124: Singapore Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  125: Singapore Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  126: Australia Market Value (US$ Mn), By Drug 2018-2022

Table  127: Australia Market Value (US$ Mn), By Drug 2023-2033

Table  128: Australia Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  129: Australia Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  130: GCC Countries Market Value (US$ Mn), By Drug 2018-2022

Table  131: GCC Countries Market Value (US$ Mn), By Drug 2023-2033

Table  132: GCC Countries Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  133: GCC Countries Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  134: South Africa Market Value (US$ Mn), By Drug 2018-2022

Table  135: South Africa Market Value (US$ Mn), By Drug 2023-2033

Table  136: South Africa Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  137: South Africa Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  138: Nigeria Market Value (US$ Mn), By Drug 2018-2022

Table  139: Nigeria Market Value (US$ Mn), By Drug 2023-2033

Table  140: Nigeria Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  141: Nigeria Market Value (US$ Mn), By Distribution Channel 2023-2033

Table  142: Israel Market Value (US$ Mn), By Drug 2018-2022

Table  143: Israel Market Value (US$ Mn), By Drug 2023-2033

Table  144: Israel Market Value (US$ Mn), By Distribution Channel 2018-2022

Table  145: Israel Market Value (US$ Mn), By Distribution Channel 2023-2033

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ペプチド治療薬（メタボリックシンドローム用）の世界市場2023年～2033年：予測・動向・分析・競争状況(Peptide-based Metabolic Disorders Therapeutics Market By Drug (Liraglutide, Exenatide), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), & Region - Global Market Insights 2023 to 2033)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • プレフィルドオートインジェクター（薬剤充填済み自動注射器）の世界市場2023年～2033年：予測・動向・分析・競争状況
  • ペプチドベース心臓血管治療薬の世界市場2023年-2033年：予測・動向・分析・競争状況
  • ペプチド感染症治療薬の世界市場2023年～2033年：予測・動向・分析・競争状況
  • 白コショウ（ホワイトペッパー）の世界市場2023年～2033年：予測・動向・分析・競争状況
  • 乳房用自動超音波装置（ABUS）の世界市場2023年-2033年：予測・動向・分析・競争状況

    • ◆H&Iグローバルリサーチのお客様（例）◆